Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07660263
Recruiting
Development of a Genomics-based Multimodal Prediction Model for Post-stroke Vascular Dementia
Not applicable · South Korea · 1 site
Registry update: 29 Jul 2026
NCT07249840
Recruiting
Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Phase 1 · United States · 1 site
Registry update: 28 Jul 2026
NCT07512427
Recruiting
Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants
Phase 1/2 · United States · 1 site
Registry update: 27 Aug 2026
NCT07724132
Recruiting
An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease
Phase 3 · United Kingdom · 2 sites
Registry update: 23 Jul 2026
NCT07685769
Recruiting
A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
Phase 4 · India · 7 sites
Registry update: 15 Oct 2026
NCT07617337
Recruiting
AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
Phase 1 · Japan, United States · 7 sites
Registry update: 18 Sept 2026
NCT07649681
Recruiting
Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention
Not applicable · Germany · 6 sites
Registry update: 20 Aug 2026
NCT07380490
Recruiting
Comparing Two PFO Closure Devices in Adults With Previous Stroke or TIA
Not applicable · Germany · 1 site
Registry update: 5 Oct 2026
NCT05996328
Recruiting
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Not applicable · United States · 21 sites
Registry update: 7 Oct 2026
NCT07551141
Recruiting
Effects of Plantar Vibration on Gait and Balance in Stroke
Not applicable · 1 site
Registry update: 2 Oct 2026
NCT07444567
Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Phase 3 · Argentina, Austria, Belgium, Canada, France, United Kingdom, Israel, India, Italy, South Korea, Netherlands, Poland, United States · 41 sites
Registry update: 27 Oct 2026
NCT07670884
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
Phase 3 · China · 2 sites
Registry update: 13 Aug 2026
NCT07744698
Recruiting
Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)
Phase 4 · China · 1 site
Registry update: 4 Aug 2026
NCT07642024
Recruiting
A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)
Phase 2/3 · China · 2 sites
Registry update: 3 Aug 2026
2025-522834-30-01
Recruiting
Fibroblast markers to tackle fibrosis in immune-mediated inflammatory diseases
Phase 2 · Netherlands · 1 site
Registry update: 29 Jun 2026
NCT07228052
Recruiting
Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
Phase 4 · United States · 1 site
Registry update: 24 Jul 2026
NCT07755436
Recruiting
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Phase 1 · United States · 6 sites
Registry update: 3 Sept 2026
NCT07722754
Recruiting
Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial
Phase 2 · China · 1 site
Registry update: 24 Sept 2026
NCT07716098
Recruiting
A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
Phase 3 · China, Japan, Taiwan, United States · 39 sites
Registry update: 3 Nov 2026
NCT07392970
Recruiting
Motixafortide for MRD Sensitization in AML
Phase 2 · United States · 1 site
Registry update: 24 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.